Skip to content

Pilates method and virtual games: strategies to improve the quality of life of women with breast cancer treated by the SUS – randomized study

Pilates Method and Augmented Reality: strategies to improve the quality of life of users of the public health system diagnosed with Breast Cancer – randomized study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
REBEC
Registry ID
RBR-7z76spy
Enrollment
Unknown
Registered
2025-01-02
Start date
2025-03-01
Completion date
Unknown
Last updated
2025-10-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast neoplasms

Interventions

This is a controlled, randomized, prospective, single-center clinical trial. Experimental group: 75 women using the SUS undergoing treatment for breast cancer, who will practice 12 Pilates method exer
E02.779.474

Sponsors

Universidade Federal de Goiás
Lead Sponsor
Universidade Federal de Goiás
Collaborator

Eligibility

Sex/Gender
Female
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: Women; over 18 years old; SUS users; diagnosed with breast cancer undergoing treatment at the Advanced Center for Breast Diagnosis at Hospital das Clínicas de Goiânia

Exclusion criteria

Exclusion criteria: Clinical, orthopedic or neurological contraindications that prevent the practice of physical activity; less than 85% of the expected frequency of activities

Design outcomes

Primary

MeasureTime frame
It is expected to improve the quality of life assessed by the questionnaire (EQ-5D-3L), with the presence of levels of health states, with only one response with digit 3, after intervention, which represents the worst state of health among the dimensions of the questionnaire, and a score of 60 on average on the Visual Analogue Scale. Data collected one week before the intervention and three months after the intervention.

Secondary

MeasureTime frame
Positive changes in composition are expected to be assessed by body mass index.;It is expected to identify a glycemic profile with normal blood glucose levels up to 100 mg/dL, and lipid profile values ??below 150 mg/dl. These values ??will be determined by laboratory tests after collecting blood samples from a peripheral vein in the week before the start of the intervention and after 3 months.

Countries

Brazil

Contacts

Public ContactNayara Lemos

Universidade Federal de Goiás

nafreitas1@ufg.br+55 62 9 85565384

Outcome results

None listed

Source: REBEC (via WHO ICTRP)